Name | CK2/PIM1-IN-1 |
---|
Description | CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1]. |
---|---|
Related Catalog | |
Target |
CK2:3.787 μM (IC50) PIM1:4.327 μM (IC50) |
In Vitro | CK2/PIM1-IN-1 a PIM kinases and CK2 inhibitor extracted from patent WO2010148351A1, Compound Example 64[1]. |
References |
[1]. Mustapha Haddach, et al. Rhodanines and related heterocycles as kinase inhibitors. WO2010148351A1. |
Molecular Formula | C15H9NO4S2 |
---|---|
Molecular Weight | 331.37 |